# 周围种植体炎治疗市场

> 种植体周围炎治疗市场研究报告按治疗类型（外科治疗、非外科治疗、再生治疗、激光治疗）、按产品（骨移植、抗菌剂、可吸收膜、化学剂）、按适应症（重度种植体周围炎、中度种植体周围炎、轻度种植体周围炎）、按最终用户（牙科诊所、医院、研究机构）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 4.99%
- **2024:** $ 2.28 Billion
- **2025:** $ 2.39 Billion
- **2035:** $ 3.9 Billion
- **Key Players:** Straumann (CH), Nobel Biocare (CH), Dentsply Sirona (US), Zimmer Biomet (US), Implant Direct (US), Osstem Implant (KR), Bicon (US), BioHorizons (US), Hiossen (KR)

**Report ID:** MRFR/MED/35170-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** September 17, 2026

**URL:** https://www.marketresearchfuture.com/reports/peri-implantitis-treatment-market-37097

---

## Market Summary

## **Peri-implantitis Treatment Market Overview**

**As per MRFR analysis, the Peri-implantitis Treatment Market Size was estimated at 2.28 (USD Billion) in 2024. The Peri-implantitis Treatment Market Industry is expected to grow from 2.39 (USD Billion) in 2025 to 3.71 (USD Billion) till 2034.**

The CAGR (growth rate) is expected to be around 4.99% during the forecast period (2025 - 2034).

## **Key Peri-implantitis Treatment Market Trends Highlighted**

The Peri-implantitis Treatment Market is experiencing significant growth driven by the rising prevalence of dental implants and the increasing awareness about oral health. As more people seek dental implants for aesthetic and functional purposes, the associated risk of peri-implantitis has become a growing concern.

This has prompted healthcare providers to focus on effective treatment options, thereby boosting market demand. Technological advancements in implant design and material have also contributed to improving patient outcomes, further driving market growth.

There are numerous opportunities within the peri-implantitis treatment landscape that stakeholders can explore. The development of innovative treatment modalities, including minimally invasive techniques, regenerative therapies, and improved diagnostic tools, presents avenues for capturing market share.

Additionally, increasing investments in research and development by dental professionals and companies are paving the way for novel solutions to manage and prevent peri-implantitis. Expanding awareness campaigns and educational initiatives aimed at both patients and dental practitioners can lead to better treatment adoption and thereby improve overall patient outcomes.

Recent trends in the market show a shift towards personalized treatment approaches, emphasizing the need for tailored solutions based on individual patient needs. There is also a growing interest in the integration of digital technologies, such as 3D imaging and AI, which can improve diagnostic accuracy and treatment planning.

Moreover, an increasing focus on preventive care and maintenance for dental implants has influenced product offerings, encouraging the development of comprehensive treatment protocols. The growing consumer demand for aesthetic dental solutions further drives innovation in this sector, making it a dynamic sphere ripe for continued growth and exploration.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Peri-implantitis Treatment Market Drivers**

### **Rising Prevalence of Peri-implantitis**

The increasing prevalence of peri-implantitis is one of the significant drivers for the growth of the Peri-implantitis Treatment Market Industry. As dental implants become more widely used among patients seeking restorative dental procedures, the incidence of complications such as peri-implantitis has also risen.

This inflammatory condition affects the soft and hard tissues surrounding the dental implants and can lead to implant failure if not addressed effectively. The growth in the aging population, coupled with a rise in the number of individuals opting for dental implants, suggests that the demand for peri-implantitis treatments will continue to escalate in the foreseeable future.

Patients' awareness of [**oral health** ](../../../reports/oral-care-market-6526)and the implications of neglected dental implants is also increasing, driving them to seek timely treatments. As a result, healthcare professionals are increasingly focusing on innovative treatment methods, leading to advancements in techniques and materials used in the Peri-implantitis Treatment Market Industry.

Furthermore, the ongoing research and development in the field of implantology are expected to enhance treatment outcomes and increase the willingness of patients to undergo these procedures, thereby positively influencing the market.

### **Advancements in Treatment Technologies**

Technological advancements in treatment options for peri-implantitis represent a crucial driver for the growth of the Peri-implantitis Treatment Market Industry. Innovations such as laser therapy, regenerative therapies, and minimally invasive surgical techniques have transformed the treatment landscape.

These advancements not only improve treatment efficacy but also significantly reduce recovery times for patients, making procedures more attractive. The introduction of new devices and technologies is expected to facilitate more effective diagnosis and targeted therapies.

The availability of a wide range of products and methodologies reinforces the market's potential for growth as healthcare providers aim to incorporate the latest innovations into their practices, ensuring better patient outcomes.

### **Growing Awareness About Oral Health**

The increasing awareness of oral health and hygiene among the general population is driving growth in the Peri-implantitis Treatment Market Industry. Education on the risks associated with peri-implantitis and the importance of maintaining proper oral hygiene practices has led to a surge in demand for prevention and treatment options.

Dental professionals are actively promoting awareness campaigns, educating patients about the impact of neglecting dental implants and the benefits of timely intervention. This heightened consciousness is motivating more patients to seek regular [**dental check-ups**](../../../reports/dental-services-market-12282), increasing the chances of early detection and treatment of peri-implantitis, thus directly contributing to market growth.

## **Peri-implantitis Treatment Market Segment Insights**

### **Peri-implantitis Treatment Market Type of Treatment Insights**

The Peri-implantitis Treatment Market is witnessing a notable evolution in its Type of Treatment segment as it is continuing to grow significantly. In 2023, the market is projected to be valued at 2.07 USD Billion and is set for an increase to 3.71 USD Billion by 2034, with various treatments playing pivotal roles in addressing peri-implantitis.

Among the treatments, Surgical Treatment stands out with a valuation of 0.85 USD Billion in 2023 and is anticipated to rise to 1.25 USD Billion by 2032, making it a dominant approach due to its effectiveness in severe cases where immediate resolution is necessary.

This segment holds a majority share in the treatment landscape, offering procedures that can yield rapid outcomes and restore the health of the implants effectively, emphasizing its critical role in patient management. In comparison, Non-Surgical Treatment is valued at 0.74 USD Billion in 2023 and is expected to grow to 1.1 USD Billion by 2032, indicating its significant but slightly lesser role compared to Surgical Treatment.

Non-surgical methods primarily include conservative therapies, which are favored for their less invasive nature and are often the first line of action for managing peri-implantitis. These methods rely on mechanical cleaning and local antiseptics, making them appealing for cases that have not progressed significantly, thereby contributing positively to the market dynamics.

Regenerative Treatment, while smaller, valued at 0.2 USD Billion in 2023 and projected to increase to 0.35 USD Billion in 2032, is becoming increasingly important as stakeholders focus on enhancing healing and tissue regeneration around implants.

This method is gaining traction as it can potentially address the underlying issues and promote the long-term stability of the implant by improving the biological environment. Although it represents a smaller segment, its growth highlights an ongoing trend toward advanced therapeutic strategies that prioritize tissue health, signaling future growth within this treatment approach.

Laser Treatment, with a valuation of 0.28 USD Billion in 2023, is on course to reach 0.5 USD Billion by 2032. This segment is emerging as a modern alternative, leveraging precision methodologies to aid in the treatment of peri-implantitis and serve patients looking for less discomfort and faster recovery times.

The adoption of laser technology reflects wider innovations in the [**dental field**](../../../reports/dental-industry-market-7637), reinforcing the importance of incorporating advanced techniques to improve patient outcomes. Overall, the diverse Type of Treatment result in a multifaceted approach to managing peri-implantitis.

Surgical and non-surgical treatments dominate the market primarily due to their established efficacy and safety profiles. At the same time, regenerative and laser treatments are carving out their space by embracing technological advancements and focusing on patient-centered care. The changing landscape emphasizes a growing awareness of the importance of tailored treatment choices for patients facing peri-implantitis, aiding in market growth and transformation.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Peri-implantitis Treatment Market Product Insights**

The Peri-implantitis Treatment Market revenue focuses on various products critical for managing peri-implantitis, a prevalent complication of dental implants. In 2023, the overall market valuation stood at 2.07 billion USD, with growth expected as awareness and diagnostic capabilities enhance.

Key products include Bone Grafts, which play a vital role in restoring bone health around implants, and Antimicrobial Agents, which are significant for preventing infection and promoting healing. Additionally, Resorbable Membranes are important because they offer a temporary barrier that aids in tissue regeneration, while Chemical Agents contribute to the bioactivity needed for effective treatment.

The market shows promising trends driven by rising dental implant procedures and a growing aging population but faces challenges like high costs and the need for extensive research. Overall, the emphasis on these product categories illustrates their importance and impact within the Peri-implantitis Treatment Market industry, as they contribute to enhanced outcomes for patients undergoing dental implant procedures.

The Peri-implantitis Treatment Market data reflects a structured segmentation aimed at ensuring comprehensive treatment options. Peri-implantitis Treatment Market Statistics show that these products will continue adapting to meet evolving therapeutic needs, thus fostering sustained market growth.

### **Peri-implantitis Treatment Market Indication Insights**

The Peri-implantitis Treatment Market is witnessing considerable growth, driven by the increasing prevalence of peri-implant diseases and a rising awareness of oral health. In 2023, the market was valued at 2.07 billion USD and is projected to reach 3.2 billion USD by 2034, indicating significant market demand.

Within this sector, the Indication segment is categorized into Severe, Moderate, and Mild Peri-implantitis, each of which presents unique challenges and treatment requirements. Severe Peri-implantitis is critical as it often leads to greater bone loss and may require more aggressive intervention, making it a focal area for **dental practitioners**.

Moderate Peri-implantitis represents a significant portion of the market, as early intervention can hinder disease progression. Meanwhile, Mild Peri-implantitis, being the most prevalent, offers lucrative opportunities for preventive treatments, emphasizing dental professionals' role in patient education and routine care.

The interplay of these categories shapes the Peri-implantitis Treatment Market statistics, highlighting the need for targeted therapies and innovative solutions that cater to the varying degrees of disease severity. As the industry evolves, advancements in treatment methodologies and consumer awareness catalyze market growth.

### **Peri-implantitis Treatment Market End User Insights**

The Peri-implantitis Treatment Market revenue is projected to experience significant growth, reflecting the increasing awareness and prevalence of peri-implantitis among dental patients. In 2023, the market was valued at 2.07 USD Billion, indicating a strong foundational presence.

A key aspect of the market segmentation is the End User category, which includes facilities such as Dental Clinics, Hospitals, and Research Institutes. Dental Clinics are particularly important, as they often serve as the first point of contact for patients seeking treatment, which positions them as a dominant player within this segment.

Hospitals are also critical as they provide comprehensive care and specialized treatment options for more severe cases of peri-implantitis. Research Institutes play a supportive role by driving innovation and advancements in treatment methods, thus impacting the overall market growth.

Overall, the emphasis on effective peri-implantitis treatment across these diverse End Users illustrates their significant contribution to the Peri-implantitis Treatment Market Statistics, including their responsiveness to the evolving needs of patients and healthcare providers alike.

### **Peri-implantitis Treatment Market Regional Insights**

The Peri-implantitis Treatment Market is witnessing notable growth across its regional segments, with an expected valuation of 2.07 USD Billion in 2023. North America leads this market with a significant majority holding, valued at 0.84 USD Billion in 2023 and projected to reach 1.21 USD Billion in 2032, driven by advanced healthcare infrastructure and increased awareness of **dental health**.

Europe follows closely, demonstrating its significance with a valuation of 0.66 USD Billion in 2023, expected to rise to 1.0 USD Billion by 2032, thanks to a growing geriatric population and rising **dental tourism**.

The APAC region, valued at 0.39 USD Billion in 2023, is projected to grow to 0.6 USD Billion by 2032 as emerging economies invest in healthcare improvements. Meanwhile, South America and MEA, being the least dominant regions with valuations of 0.11 USD Billion and 0.07 USD Billion in 2023, respectively, are gradually expanding, bolstered by increasing access to dental treatments and rising disposable incomes.

Overall, the Peri-implantitis Treatment Market segmentation reflects diverse growth patterns influenced by regional healthcare dynamics and market opportunities.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Peri-implantitis Treatment Market Key Players and Competitive Insights**

The Peri-implantitis Treatment Market has gained significant attention due to the increasing prevalence of periodontal diseases and the rising demand for dental implants globally. This market presents a dynamic environment characterized by a variety of treatment modalities, including surgical interventions, non-surgical therapy, and innovative products aimed at managing and preventing peri-implantitis.

Key players in the market are leveraging advancements in technology and the development of new products to enhance their offerings and cater to the evolving needs of healthcare professionals and patients alike. The competitive landscape features a mix of established players and new entrants vying for market share, driven by factors such as product efficacy, pricing strategies, and distribution networks.

As dental practitioners seek efficient solutions for peri-implantitis, companies are focusing on research and development to introduce novel therapies and improve existing treatment options, thereby intensifying competition within the market.

Magma has positioned itself as a significant player in the Peri-implantitis Treatment Market, recognized for its innovative approach towards treatment solutions. The company boasts a robust pipeline of products specifically designed for addressing peri-implantitis, ensuring that healthcare providers have access to effective tools for managing this condition.

Magma's strong emphasis on research and development allows it to stay ahead of competitors, producing cutting-edge therapies that incorporate the latest advancements in dental technology. Furthermore, Magma has established a solid market presence through strategic collaborations with dental practitioners and educational institutions, enhancing its brand recognition and credibility in the sector.

The company's commitment to continuous improvement and customer satisfaction has fortified its position within the competitive landscape, making it a notable entity in the pursuit of effective peri-implantitis treatments.

Coltene is another important contributor to the Peri-implantitis Treatment Market, known for its comprehensive range of dental products that cater to various treatment needs. The company thrives on its high-quality offerings, including specialized materials for dental implants and effective peri-implantitis treatment options, which are crafted with precision and reliability in mind.

Coltene’s extensive experience in the dental industry has enabled it to build a loyal customer base, underpinning its established reputation for excellence. Leveraging its advanced manufacturing processes and stringent quality control measures, the company ensures that its products meet the highest standards, which has allowed it to maintain strong relationships with dental professionals globally.

Additionally, Coltene's focus on providing educational resources and training further enhances its value proposition, ensuring that practitioners are well-equipped to utilize its products effectively while addressing peri-implantitis challenges. This strategy not only reinforces Coltene's market presence but also contributes positively to the overall evolution of treatment approaches in the sector.

### **Key Companies in the Peri-implantitis Treatment Market Include**

## **Peri-implantitis Treatment Market Industry Developments**

Recent developments in the Peri-implantitis Treatment Market indicate significant advancements in both technology and clinical practices. Companies such as Nobel Biocare and Straumann Holding have launched innovative treatment solutions aimed at enhancing patient outcomes, focusing on effective management and prevention of peri-implantitis.

The rise in **[dental implant](../../../reports/dental-implants-market-2753) procedures** is driving demand for effective peri-implantitis treatments and contributing to market expansion. Notably, mergers and acquisitions within the sector have been prominent, with companies like Dentsply Sirona acquiring various smaller entities to strengthen their product offerings and market reach.

Additionally, Zimmer Biomet has been reported to expand its portfolio through strategic partnerships that enhance treatment options. The growth valuation of these companies, including Magma and Coltene, is indicative of increased investment in R&D, allowing for the development of potent solutions that address peri-implant complications more effectively.

The collective efforts from various market players not only highlight the competitive landscape but also signal a robust movement towards improving therapeutic outcomes in oral health care, particularly in the management of peri-implantitis.

## **Peri-implantitis Treatment Market Segmentation Insights**

### **Peri-implantitis Treatment Market Type of Treatment Outlook**

- Surgical Treatment
- Non-Surgical Treatment
- Regenerative Treatment
- Laser Treatment

### **Peri-implantitis Treatment Market Product Outlook**

- Bone Grafts
- Antimicrobial Agents
- Resorbable Membranes
- Chemical Agents

### **Peri-implantitis Treatment Market Indication Outlook**

- Severe Peri-implantitis
- Moderate Peri-implantitis
- Mild Peri-implantitis

### **Peri-implantitis Treatment Market End User Outlook**

- Dental Clinics
- Hospitals
- Research Institutes

### **Peri-implantitis Treatment Market Regional Outlook**

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### 增加对牙科研究的投资

种植体周围炎治疗市场受益于对牙科研究与开发的投资增加。各国政府和私人组织正在分配大量资金，以探索创新的治疗方式并改善现有疗法。这一资金的涌入促进了学术机构与牙科公司的合作，导致对种植体周围炎病理生理学的突破性理解。研究计划专注于开发针对该病症根本原因的靶向疗法，这可能会彻底改变治疗方法。随着新发现的出现，它们可能会转化为增强的治疗选择，从而刺激市场增长，扩大从业者可用的治疗范围。

### 先进治疗方案的监管支持

种植体周围炎治疗市场受到对先进治疗方案的监管支持的积极影响。监管机构越来越认识到解决种植体周围炎的重要性，并正在简化新疗法的批准流程。这种支持性环境鼓励创新治疗解决方案的开发和商业化。例如，某些为种植体周围炎治疗设计的生物材料和设备的加速批准正在促进它们进入市场。随着监管框架的发展以适应牙科技术的进步，临床医生更有可能采用这些新治疗，从而推动市场增长。监管支持与临床需求的对齐预计将增强种植体周围炎治疗的整体格局。

### 种植体周围炎发病率上升

种植体周围炎治疗市场受到种植体患者中种植体周围炎发病率上升的显著影响。研究表明，约有10-20%的种植体患者可能会发展为种植体周围炎，从而导致对有效治疗方案的需求增加。这种日益增长的流行率归因于口腔卫生差、吸烟和系统性疾病等因素，这些因素加重了病情。随着人们对维护口腔健康重要性的认识不断提高，越来越多的患者寻求预防和治疗措施。因此，牙科从业者被迫扩大其治疗服务，从而推动市场向前发展。每年种植的牙齿数量的增加进一步促进了对种植体周围炎治疗的需求。

### 对微创手术的需求不断增长

种植体周围炎治疗市场正朝着微创手术的方向发展，这一趋势受到患者对较少创伤性治疗选项的偏好驱动。患者越来越倾向于寻求能够提供更快恢复时间和减少不适感的治疗。这一趋势促使牙科专业人士采用能够最小化组织损伤的技术，同时有效应对种植体周围炎。诸如引导组织再生和使用生物相容性材料等创新正在获得关注，因为它们符合对较少侵入性干预的需求。因此，随着从业者将这些技术纳入其治疗方案，市场可能会扩大，以满足患者不断变化的期望。

### 种植体周围炎治疗中的技术创新

种植体周围炎治疗市场正在经历技术创新的激增，这些创新提高了治疗的有效性。先进的激光疗法、再生技术和新型生物材料正在被整合到治疗方案中。例如，激光辅助治疗的引入在减少炎症和促进组织再生方面显示出良好的效果。根据最近的数据，这些技术的采用预计将使治疗成功率提高约30%。此外，数字成像和诊断工具的发展使得对种植体周围炎的更精确识别成为可能，从而促进及时干预。这一技术演变不仅改善了患者的治疗结果，还推动了市场的增长，因为牙科专业人士寻求采用最新的进展来提升他们的实践。

## Future Outlook

种植体周围炎治疗市场预计将在2024年至2035年间以4.99%的年均增长率增长，推动因素包括种植体疾病的日益普遍和治疗技术的进步。

**New opportunities:**

- 针对种植体周围炎管理的靶向抗菌疗法的开发。

到2035年，市场预计将实现显著增长，反映出治疗范式的演变和患者意识的提高。

## Segment Insights

### 按治疗类型：外科治疗（最大）与非外科治疗（增长最快）

种植体周围炎治疗市场在治疗选项类型之间显示出明显的细分份额，其中外科治疗占据市场主导地位。这一优势可归因于其在严重病例中的有效性，吸引了寻求全面解决方案的临床医生和患者。相比之下，非外科治疗因其微创特性和成本效益而逐渐受到关注，特别是在一个日益关注患者舒适度和可负担性的环境中。

外科治疗（主导）与非外科治疗（新兴）

外科治疗在种植体周围炎治疗市场中占据主导地位，主要是由于其在处理已发生显著骨质流失的晚期种植体周围炎方面的有效性。这种治疗的特点是采用如翻瓣手术等程序，允许对种植体表面进行彻底清洁并加强周围组织。另一方面，非外科治疗作为一种竞争性替代方案正在兴起，专注于如刮治和根面平整等技术。该细分市场的增长受到患者偏好较少侵入性方法的推动，导致临床医生越来越接受作为一种可行的初始治疗选择。

### 按产品分类：骨移植（最大）与抗菌剂（增长最快）

在种植体周围炎治疗市场中，产品细分主要由四个关键类别组成：骨移植、抗微生物剂、可吸收膜和化学剂。骨移植在市场中占有重要份额，因为它们在促进骨再生和牙科种植体周围的愈合方面的应用已得到确立。该细分市场的需求稳定，因为牙科专业人士越来越认识到在种植体周围炎发生后有效骨修复的重要性。相反，抗微生物剂因其在对抗与种植体周围炎相关的感染方面的有效性而迅速获得关注。随着对治疗选择的认识不断提高，针对特定细菌特征的抗微生物解决方案的偏好也在增加，使得这一类别成为该细分市场中增长最快的部分。

骨移植（主导）与抗微生物剂（新兴）

骨移植目前在围种植体炎治疗市场的产品细分中占据主导地位，因为它们在骨生成中的关键作用。它们被广泛用于恢复骨质流失并增强受围种植体炎影响的牙科植体的稳定性。随着移植材料和技术的不断进步，骨移植的疗效持续提高，巩固了其市场地位。同时，抗菌剂作为治疗方案的重要组成部分正在崭露头角，提供创新的解决方案以预防和治疗感染。这些药剂有助于减轻细菌对愈合过程的不利影响，使其成为从业者的首选。随着这些产品的发展和临床证据的增加，骨移植和抗菌剂可能在改善治疗结果方面发挥关键作用。

### 按适应症：严重的种植体周围炎（最大）与中度的种植体周围炎（增长最快）

在种植体周围炎治疗市场中，各种适应症的市场份额分布显示，重度种植体周围炎因其在患者中的普遍性而占据最大份额。中度和轻度种植体周围炎虽然也很重要，但在市场代表性方面落后，治疗工作主要集中在重度病例上，因为这些病例的复杂性和更高的治疗需求。这表明，医生和患者都强烈认识到有效应对重度种植体周围炎的紧迫性。
这一细分市场的增长趋势受到对种植体周围疾病认识提高和治疗方法进步的推动。新兴技术、改进的诊断工具以及老龄化的种植体人口是推动中度种植体周围炎治疗增加的重要因素。随着口腔健康教育的提高，种植体周围病症的主动管理也在增加，特别是在中度病例中，使其成为该市场中增长最快的细分领域。

指示：严重的种植体周围炎（主导）与轻度的种植体周围炎（新兴）

严重的种植体周围炎被认为是治疗领域的主要指征，主要是由于其对患者健康的严重影响以及对密集治疗方案的必要性。该领域的特点是临床关注度更高，导致更全面的治疗计划和干预措施。相比之下，轻度种植体周围炎虽然在当前市场上存在感较低，但被视为一种正在获得关注的新兴指征。随着患者信息的增加，对早期治疗的兴趣日益增长，为制造商开发针对性解决方案创造了机会。这两个领域共同展示了市场的动态特性，随着患者需求和期望的变化而不断适应。

### 按最终用户：牙科诊所（最大）与医院（增长最快）

种植体周围炎治疗市场在很大程度上受到终端用户分布的影响，主要由牙科诊所主导。这些诊所占据了市场的显著份额，提供针对种植体周围炎管理的专业治疗和服务。相反，医院虽然市场份额较小，但作为增长最快的细分市场正在崛起，主要得益于其处理复杂病例的能力和对患者护理的综合方法。研究机构也发挥着关键作用，专注于治疗方法的创新和进步。

牙科诊所（主导）与医院（新兴）

牙科诊所凭借以患者为中心的服务和与接受牙科治疗的个人频繁互动，已在种植体周围炎治疗市场中确立了主导地位。这些诊所提供针对种植体相关问题的专业护理，确保包括诊断和后续治疗在内的全面治疗方案。另一方面，医院作为一个新兴领域，正在加大其种植体周围炎治疗的力度，以应对更严重的病例，并利用其多学科的治疗方法。随着转诊病例和协作治疗机会的增加，医院有望在这一市场中巩固其地位。

## Regional Market Share Analysis

种植体周围炎治疗市场在各地区段中正经历显著增长，预计在2023年的估值为20.7亿美元。北美在该市场中占据主导地位，2023年的估值为8.4亿美元，预计到2032年将达到12.1亿美元，这得益于先进的医疗基础设施和对**牙齿健康**的日益关注。

欧洲紧随其后，2023年的估值为6.6亿美元，预计到2032年将上升至10亿美元，这得益于老年人口的增长和日益增加的**牙科旅游**。

亚太地区在2023年的估值为3.9亿美元，预计到2032年将增长至6亿美元，因为新兴经济体正在投资于医疗保健的改善。与此同时，南美和中东及非洲地区是最不占主导地位的地区，2023年的估值分别为1.1亿美元和0.7亿美元，正在逐渐扩展，得益于对牙科治疗的日益可及性和可支配收入的增加。

总体而言，种植体周围炎治疗市场的细分反映了受地区医疗动态和市场机会影响的多样化增长模式。

来源：初步研究，二次研究，_市场研究未来_数据库和分析师评审

## Competitive Benchmarking

种植体周围炎治疗市场因牙周病的日益普遍和全球对牙科种植体需求的增加而受到广泛关注。该市场呈现出一个动态环境，具有多种治疗方式，包括外科干预、非外科治疗和旨在管理和预防种植体周围炎的创新产品。

市场中的主要参与者正在利用技术进步和新产品的开发来增强其产品，满足医疗专业人员和患者不断变化的需求。竞争格局中既有成熟的参与者，也有新进入者争夺市场份额，推动因素包括产品有效性、定价策略和分销网络。

随着牙科从业者寻求有效的种植体周围炎解决方案，公司专注于研究和开发，以推出新疗法并改善现有治疗选择，从而加剧市场竞争。

Magma已将自己定位为种植体周围炎治疗市场的重要参与者，以其创新的治疗解决方案而闻名。该公司拥有一条强大的产品管道，专门设计用于解决种植体周围炎，确保医疗提供者能够获得有效的管理工具。

Magma对研究和开发的强烈重视使其能够在竞争中保持领先，生产出结合最新牙科技术进展的尖端疗法。此外，Magma通过与牙科从业者和教育机构的战略合作建立了稳固的市场存在，增强了其品牌认知度和在该领域的信誉。

该公司对持续改进和客户满意度的承诺巩固了其在竞争格局中的地位，使其成为追求有效种植体周围炎治疗的显著实体。

Coltene是种植体周围炎治疗市场的另一个重要贡献者，以其全面的牙科产品系列满足各种治疗需求而闻名。该公司凭借其高质量的产品蓬勃发展，包括为牙科种植体提供的专业材料和有效的种植体周围炎治疗选项，这些产品在精确性和可靠性方面经过精心设计。

Coltene在牙科行业的丰富经验使其能够建立忠实的客户基础，巩固了其卓越的声誉。通过利用其先进的制造工艺和严格的质量控制措施，该公司确保其产品符合最高标准，这使其能够与全球的牙科专业人士保持良好的关系。

此外，Coltene专注于提供教育资源和培训，进一步增强了其价值主张，确保从业者能够有效利用其产品，同时应对种植体周围炎的挑战。这一策略不仅巩固了Coltene的市场存在，还对该领域治疗方法的整体演变产生了积极影响。

## Recent News & Developments

近期关于种植体周围炎治疗市场的发展表明，技术和临床实践都有显著进步。像诺贝尔生物护理和施特劳曼控股等公司推出了创新的治疗方案，旨在改善患者的治疗效果，专注于有效管理和预防种植体周围炎。

种植体手术的**需求**推动了对有效种植体周围炎治疗的需求，并促进了市场的扩展。值得注意的是，行业内的并购活动非常活跃，像登士柏西罗纳等公司收购了多家较小的企业，以增强其产品供应和市场覆盖。

此外，Zimmer Biomet被报道通过战略合作伙伴关系扩展其产品组合，以增强治疗选择。这些公司，包括Magma和Coltene的增长估值，表明对研发的投资增加，使得能够开发出更有效解决种植体并发症的强大解决方案。

各市场参与者的共同努力不仅突显了竞争格局，还标志着在口腔医疗保健中，特别是在种植体周围炎管理方面，改善治疗效果的强劲趋势。

## Report Scope

| 2024年市场规模 | 22.8（亿美元） |
| --- | --- |
| 2025年市场规模 | 23.94（亿美元） |
| 2035年市场规模 | 38.96（亿美元） |
| 复合年增长率（CAGR） | 4.99%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 激光治疗和再生技术的进步提高了种植体周围炎治疗市场的治疗效果。 |
| 主要市场动态 | 种植体周围炎的发病率上升推动了对创新治疗解决方案的需求，并增强了竞争市场动态。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，围植体炎治疗市场的预计市场估值是多少？**
A: 到2035年，围种植体炎治疗市场预计将达到约39.96亿美元。

**Q: 2024年围种植体炎治疗市场的市场估值是多少？**
A: 在2024年，围种植体炎治疗市场的市场估值为22.8亿美元。

**Q: 2025年至2035年，围植体炎治疗市场的预期CAGR是多少？**
A: 在2025年至2035年的预测期内，围种植体炎治疗市场的预期CAGR为4.99%。

**Q: 到2035年，预计在种植体周围炎治疗市场中，哪个细分市场的估值最高？**
A: 非手术治疗领域预计到2035年将达到约15亿美元。

**Q: 在种植体周围炎治疗市场中，主要参与者有哪些？**
A: 市场上的主要参与者包括Straumann、Nobel Biocare、Dentsply Sirona、Zimmer Biomet等。

**Q: 到2035年，外科治疗的估值与非外科治疗相比如何？**
A: 到2035年，外科治疗的估值预计将达到约12亿美元，而非外科治疗的估值预计为15亿美元。

**Q: 到2035年，骨移植在围种植体炎治疗市场的预期市场规模是多少？**
A: 到2035年，骨移植市场规模预计将达到约12亿美元。

**Q: 到2035年，预计哪个最终用户细分市场将主导围种植体炎治疗市场？**
A: 预计到2035年，牙科诊所将主导市场，估计价值约为15.7亿美元。

**Q: 到2035年，适度种植体周围炎治疗的预计估值是多少？**
A: 预计到2035年，中度种植体周围炎治疗的估值将达到约11.56亿美元。

**Q: 抗微生物剂在种植体周围炎治疗市场中扮演什么角色？**
A: 抗微生物剂预计到2035年将达到约15亿美元的估值，表明它们在治疗中的关键作用。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/peri-implantitis-treatment-market-37097*